Polyrizon Ltd. Ordinary Shares (PLRZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Polyrizon Ltd. Ordinary Shares (PLRZ) has a cash flow conversion efficiency ratio of -0.099x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.82 Million) by net assets ($18.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PLRZ cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Polyrizon Ltd. Ordinary Shares - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Polyrizon Ltd. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Polyrizon Ltd. Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Polyrizon Ltd. Ordinary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SemiLEDS Corporation
F:6LD1
|
0.800x |
|
Boule Diagnostics AB
ST:BOUL
|
-0.017x |
|
exax Inc
KQ:060230
|
-0.030x |
|
Xelpmoc Design And Tech Limited
NSE:XELPMOC
|
-0.051x |
|
oodash Group AB (publ)
ST:OODA
|
N/A |
|
Vichitbhan Palmoil Public Company Limited
BK:VPO
|
-0.267x |
|
Country Heights Holdings Bhd
KLSE:5738
|
0.005x |
|
Dolphin Entertainment Inc
NASDAQ:DLPN
|
0.060x |
Annual Cash Flow Conversion Efficiency for Polyrizon Ltd. Ordinary Shares (2020–2024)
The table below shows the annual cash flow conversion efficiency of Polyrizon Ltd. Ordinary Shares from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see PLRZ market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $5.29 Million | $-1.15 Million | -0.217x | -107.72% |
| 2023-12-31 | $-191.00K | $-537.00K | 2.812x | +61.94% |
| 2022-12-31 | $-652.00K | $-1.13 Million | 1.736x | -98.94% |
| 2021-12-31 | $-3.00K | $-492.00K | 164.000x | +3694.52% |
| 2020-12-31 | $16.00K | $-73.00K | -4.563x | -- |
About Polyrizon Ltd. Ordinary Shares
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nas… Read more